Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 3Phase 3 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Hepatitis B 3Carcinoma, Hepatocellular 3Lymphoma, Non-Hodgkin 1

Interventions

entecavir 3polysaccharide MGN3 1lens intermediate filament proteins 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Rapid Diagnostic Tests 1Radiofrequency Ablation 1Polymorphism, Genetic 1Pneumococcal Vaccines 1Measles-Mumps-Rubella Vaccine 1Lamivudine 1Hypothermia, Induced 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Enzyme-Linked Immunosorbent Assay 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Hepatitis B × entecavir × Clear all
NCT07253220 2025-11-28

TAF Monotherapy Versus ETV Combined With TAF on the Efficacy and Prognosis of Immunotherapy for Hepatitis B-Related Hepatocellular Carcinoma

Sun Yat-sen University

Phase NA Not yet recruiting
120 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT00824707 2016-04-01

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

NCT01018381 2009-11-23

Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection

The 108 Military Central Hospital

Phase NA Completed
130 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡